Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Dokl Biochem Biophys ; 483(1): 337-340, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30607734

ABSTRACT

The results of the study of the effect of mononuclear dinitrosyl iron complexes (DNICs) with functional sulfur-containing ligands (NO donors) on the cell viability and metabolism of human lung fibroblasts are presented, and the efficiency of their action is evaluated. It was shown that cationic DNICs increased the cell viability of fibroblasts and demonstrated the cytoprotective properties. Fluorescent analysis revealed that the DNICs compounds decrease the mitochondrial membrane potential but do not have a significant effect on the level of glutathione and reactive oxygen species in fibroblasts. It is assumed that the DNICs have the therapeutic potential for treating cardiovascular diseases.


Subject(s)
Fibroblasts/metabolism , Iron/pharmacology , Lung/metabolism , Membrane Potential, Mitochondrial/drug effects , Nitric Oxide Donors/pharmacology , Nitrogen Oxides/pharmacology , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/pathology , Cell Survival/drug effects , Fibroblasts/pathology , Humans , Lung/pathology
2.
Bull Exp Biol Med ; 163(1): 54-56, 2017 May.
Article in English | MEDLINE | ID: mdl-28580521

ABSTRACT

We studied the effects of water-soluble cationic dinitrosyl iron complexes with thiocarbamide and its aliphatic derivatives, new synthetic analogs of natural NO donors, active centers of nitrosyl [1Fe-2S]proteins, on activities of Ca2+-ATPase of sarcoplasmic reticulum and cGMP phosphodiesterase. Nitrosyl iron complexes [Fe(C3N2H8S)Cl(NO)2]0[Fe(NO)2(C3N2H8S)2]+Cl- (I), [Fe(SC(N(CH3)2)2(NO)2]Cl (II), [Fe(SC(NH2)2)2(NO)2Cl×H2O (III), and [Fe(SC(NH2)2)2(NO)2]2SO4×H2O (IV) in a concentration of 10-4 M completely inhibited the transporting and hydrolytic functions of Ca2+-ATPase. In a concentration of 10-5 M, they inhibited active Ca2+ transport by 57±6, 75±8, 80±8, and 85±9% and ATP hydrolysis by 0, 40±4, 48±5, and 38±4%, respectively. Complex II reversibly and noncompetitively inhibited the hydrolytic function of Ca2+-ATPase (Ki=1.7×10-6 M). All the studied iron-sulphur complexes in a concentration of 10-4 M inhibited cGMP phosphodiesterase function. These data suggest that the studied complexes can exhibit antimetastatic, antiaggregation, vasodilatatory, and antihypertensive activities.


Subject(s)
Calcium-Transporting ATPases/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 1/metabolism , Ferrous Compounds/chemistry , Nitro Compounds/chemistry , Sarcoplasmic Reticulum/chemistry , Sarcoplasmic Reticulum/enzymology , Adenosine Triphosphate , Animals , Biological Transport/drug effects , Enzyme Activation/drug effects , Ferrous Compounds/pharmacology , Kinetics , Nitro Compounds/pharmacology , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL